{"id":1770,"date":"2025-07-24T17:10:16","date_gmt":"2025-07-24T15:10:16","guid":{"rendered":"https:\/\/okuvision.de\/okuvision-homepage\/"},"modified":"2026-05-03T14:33:15","modified_gmt":"2026-05-03T12:33:15","slug":"okuvision","status":"publish","type":"page","link":"https:\/\/okuvision.de\/en\/","title":{"rendered":"Okuvision Homepage"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;0&#8243; back_color=&#8221;color-jevc&#8221; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; cvc_pattern_bottom_right=&#8221;pattern2&#8243; uncode_shortcode_id=&#8221;790913&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;172061&#8243;][vc_custom_heading text_color=&#8221;color-233806&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-431854&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;599256&#8243; text_color_type=&#8221;uncode-palette&#8221;]Okuvision \u2013<br \/>\nSehen erhalten[\/vc_custom_heading][vc_column_text text_lead=&#8221;yes&#8221; uncode_shortcode_id=&#8221;317416&#8243;]Our Innovation Against Progression<br \/>\nOkuStim\u00ae therapy for patients with retinitis pigmentosa[\/vc_column_text][vc_empty_space empty_h=&#8221;4&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221;][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;bottom&#8221; gutter_size=&#8221;3&#8243; override_padding=&#8221;yes&#8221; column_padding=&#8221;0&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;140350&#8243;][vc_single_image media=&#8221;1772&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;164953&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;150023&#8243;][vc_column width=&#8221;1\/2&#8243;][vc_single_image media=&#8221;1773&#8243; media_width_percent=&#8221;100&#8243; media_ratio=&#8221;sixteen-nine&#8221; uncode_shortcode_id=&#8221;196860&#8243;][vc_custom_heading uncode_shortcode_id=&#8221;439502&#8243;]OkuStim\u00ae therapy: Effect &amp; Application[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;149199&#8243;]OkuStim\u00ae therapy can slow the progression of visual field loss in patients with retinitis pigmentosa (RP). This can delay severe impairments due to vision loss.<br \/>OkuStim\u00ae therapy with transcorneal electrical stimulation (TES) involves the introduction of weak electrical impulses into the eye via the cornea. These impulses then spread throughout the eye, stimulating certain cells in the retina. The aim is to activate protective mechanisms in the retina that can slow down the progression of the disease and prevent or delay the onset of later stages of RP.[\/vc_column_text][vc_button button_color=&#8221;color-312440&#8243; size=&#8221;link&#8221; btn_link_underline=&#8221;btn-underline-in&#8221; custom_typo=&#8221;yes&#8221; font_family=&#8221;font-153386&#8243; font_weight=&#8221;700&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:https%3A%2F%2Fokuvision.de%2Fen%2Fretinitis-pigmentosa-treatment%2F|title:%20TES%20Therapy&#8221; button_color_type=&#8221;uncode-palette&#8221; icon=&#8221;fa fa-arrow-right2&#8243; uncode_shortcode_id=&#8221;153424&#8243;]TES Therapy[\/vc_button][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image media=&#8221;1774&#8243; media_width_percent=&#8221;100&#8243; media_ratio=&#8221;sixteen-nine&#8221; uncode_shortcode_id=&#8221;515311&#8243;][vc_custom_heading uncode_shortcode_id=&#8221;781087&#8243;]Clinical Trails: Design, Safety &amp; Evaluation (G-BA)[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;127878&#8243;]Clinical Trials show that regular use of OkuStim\u00ae can maintain retinal activity and preserve vision longer. Furthermore, the safety of its application has been unequivocally proven. The long-term effect is currently being evaluated in a trial funded by health insurance companies. Randomized and multicenter studies are progressively strengthening the evidence base.[\/vc_column_text][vc_button button_color=&#8221;color-312440&#8243; size=&#8221;link&#8221; btn_link_underline=&#8221;btn-underline-in&#8221; custom_typo=&#8221;yes&#8221; font_family=&#8221;font-153386&#8243; font_weight=&#8221;700&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:https%3A%2F%2Fokuvision.de%2Fen%2Fretinitis-pigmentosa-research-evidence%2F|title:Clinical%20Trials%20and%20Research&#8221; button_color_type=&#8221;uncode-palette&#8221; icon=&#8221;fa fa-arrow-right2&#8243; uncode_shortcode_id=&#8221;506240&#8243;]Clinical Trials[\/vc_button][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-206913&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;513232&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_right&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;124613&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;124843&#8243;]Experiences with OkuStim\u00ae[\/vc_custom_heading][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;667383&#8243;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; back_color=&#8221;color-942029&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; cvc_column_pattern_top_left=&#8221;pattern&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;458144&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_single_image media=&#8221;1775&#8243; media_width_use_pixel=&#8221;yes&#8221; media_ratio=&#8221;one-one&#8221; uncode_shortcode_id=&#8221;316289&#8243; media_width_pixel=&#8221;160&#8243; media_link=&#8221;url:%2Fnews%2Ferfahrungen-mit-rp-okustim-anja-renner%2F|title:Erfahrungsbericht%20%E2%80%93%20Anja%20Renner&#8221;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;132320&#8243;]Anja Renner \u2013 Don&#8217;t Give Up[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;112256&#8243;]Paratriathlete with Usher syndrom, &lt;10% residual vision \u2013 her mantra: don&#8217;t give up, adapt step by step, stay mentally strong.[\/vc_column_text][vc_button button_color=&#8221;color-312440&#8243; size=&#8221;link&#8221; btn_link_underline=&#8221;btn-underline-in&#8221; custom_typo=&#8221;yes&#8221; font_family=&#8221;font-153386&#8243; font_weight=&#8221;700&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:https%3A%2F%2Fokuvision.de%2Fen%2Fnews%2Fexperiences-with-rp-okustim-anja-renner%2F|title:Patient%20Story%20%E2%80%93%20Anja%20Renner&#8221; button_color_type=&#8221;uncode-palette&#8221; icon=&#8221;fa fa-arrow-right2&#8243; uncode_shortcode_id=&#8221;182196&#8243;]Read Anja&#8217;s Story[\/vc_button][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; back_color=&#8221;color-942029&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; cvc_column_pattern_bottom_right=&#8221;pattern&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;428122&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_single_image media=&#8221;1776&#8243; media_width_use_pixel=&#8221;yes&#8221; media_ratio=&#8221;one-one&#8221; uncode_shortcode_id=&#8221;168358&#8243; media_width_pixel=&#8221;160&#8243; media_link=&#8221;url:%2Fnews%2Ferfahrungsbericht-rp-reinhard%2F|title:Portr%C3%A4t%20Reinhard%20John%20lesen&#8221;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;131286&#8243;]Reinhard John \u2013 Everything but Flying[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;196294&#8243;]Ex-pilot with RP relies on TES to stabilize his current vision status for as long as possible; training and clear routines provide structure.[\/vc_column_text][vc_button button_color=&#8221;color-312440&#8243; size=&#8221;link&#8221; btn_link_underline=&#8221;btn-underline-in&#8221; custom_typo=&#8221;yes&#8221; font_family=&#8221;font-153386&#8243; font_weight=&#8221;700&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:https%3A%2F%2Fokuvision.de%2Fen%2Fnews%2Fexperience-report-rp-reinhard%2F|title:Read%20Reinhard%27s%20Story&#8221; button_color_type=&#8221;uncode-palette&#8221; icon=&#8221;fa fa-arrow-right2&#8243; uncode_shortcode_id=&#8221;881906&#8243;]Read Reinhard&#8217;s Story[\/vc_button][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; override_padding=&#8221;yes&#8221; column_padding=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;627315&#8243;][vc_button button_color=&#8221;color-312440&#8243; border_width=&#8221;0&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:https%3A%2F%2Fokuvision.de%2Fen%2Fpatient-stories%2F|title:Patient%20Stories&#8221; button_color_type=&#8221;uncode-palette&#8221; icon=&#8221;fa fa-arrow-right2&#8243; uncode_shortcode_id=&#8221;209765&#8243;]Patient Stories[\/vc_button][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_section][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;102049&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;110830&#8243;]Discover the Okuvision Story[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; cvc_maxwidth=&#8221;1920&#8243; uncode_shortcode_id=&#8221;490954&#8243;][vc_column width=&#8221;2\/3&#8243;][vc_single_image media=&#8221;1777&#8243; media_width_percent=&#8221;100&#8243; media_ratio=&#8221;sixteen-nine&#8221; uncode_shortcode_id=&#8221;168334&#8243;][\/vc_column][vc_column column_width_percent=&#8221;70&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; override_padding=&#8221;yes&#8221; column_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;126108&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;145717&#8243;]Our History[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;106583&#8243;]Since 2007 on the path from research to care; CE mark 2014, OkuStim\u00ae 2 approval in 2025. Today, a Europe-wide network &amp; continuous development.[\/vc_column_text][vc_button button_color=&#8221;color-312440&#8243; size=&#8221;link&#8221; btn_link_underline=&#8221;btn-underline-in&#8221; custom_typo=&#8221;yes&#8221; font_family=&#8221;font-153386&#8243; font_weight=&#8221;700&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:https%3A%2F%2Fokuvision.de%2Fen%2Fokuvison-story%2F|title:Our%20History&#8221; button_color_type=&#8221;uncode-palette&#8221; icon=&#8221;fa fa-arrow-right2&#8243; uncode_shortcode_id=&#8221;176494&#8243;]Our History[\/vc_button][\/vc_column][\/vc_row][vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; inverted_device_order=&#8221;yes&#8221; content_parallax=&#8221;0&#8243; cvc_maxwidth=&#8221;1920&#8243; uncode_shortcode_id=&#8221;647842&#8243;][vc_column column_width_percent=&#8221;70&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; override_padding=&#8221;yes&#8221; column_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;833365&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;145778&#8243;]Our Motivation[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;198243&#8243;]Preserving vision \u2013 act today: We combine scientific diligence, technical quality, and clear communication \u2013 for self-determined decisions and tangible benefits in everyday life.[\/vc_column_text][vc_button button_color=&#8221;color-312440&#8243; size=&#8221;link&#8221; btn_link_underline=&#8221;btn-underline-in&#8221; custom_typo=&#8221;yes&#8221; font_family=&#8221;font-153386&#8243; font_weight=&#8221;700&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:https%3A%2F%2Fokuvision.de%2Fen%2Fmotivation%2F|title:Understand%20Our%20Motivation&#8221; button_color_type=&#8221;uncode-palette&#8221; icon=&#8221;fa fa-arrow-right2&#8243; uncode_shortcode_id=&#8221;184750&#8243;]Understand Our Motivation[\/vc_button][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243; uncode_shortcode_id=&#8221;158877&#8243;][vc_single_image media=&#8221;1773&#8243; media_width_percent=&#8221;100&#8243; media_ratio=&#8221;sixteen-nine&#8221; uncode_shortcode_id=&#8221;180237&#8243;][\/vc_column][\/vc_row][vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;4&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; cvc_maxwidth=&#8221;1920&#8243; uncode_shortcode_id=&#8221;128198&#8243;][vc_column width=&#8221;2\/3&#8243;][vc_single_image media=&#8221;1778&#8243; media_width_percent=&#8221;100&#8243; media_ratio=&#8221;sixteen-nine&#8221; uncode_shortcode_id=&#8221;107723&#8243;][\/vc_column][vc_column column_width_percent=&#8221;70&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; override_padding=&#8221;yes&#8221; column_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;126108&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;993375&#8243;]Our Network[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;125485&#8243;]Together with PRO RETINA, Retina Suisse, and Retina International, we strengthen awareness &amp; care; close networking with clinics and study centers.[\/vc_column_text][vc_button button_color=&#8221;color-312440&#8243; size=&#8221;link&#8221; btn_link_underline=&#8221;btn-underline-in&#8221; custom_typo=&#8221;yes&#8221; font_family=&#8221;font-153386&#8243; font_weight=&#8221;700&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:https%3A%2F%2Fokuvision.de%2Fen%2Fnetwork%2F|title:Our%20Network&#8221; button_color_type=&#8221;uncode-palette&#8221; icon=&#8221;fa fa-arrow-right2&#8243; uncode_shortcode_id=&#8221;751645&#8243;]Our Network[\/vc_button][\/vc_column][\/vc_row][\/vc_section][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-206913&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;170728&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;4&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;152446&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;109998&#8243;]Insights into Therapy,<br \/>\nResearch &amp; Company[\/vc_custom_heading][vc_row_inner][vc_column_inner width=&#8221;1\/1&#8243;][uncode_index el_id=&#8221;index-974899&#8243; index_type=&#8221;carousel&#8221; loop=&#8221;size:6|order_by:date|post_type:post|taxonomy_count:10&#8243; carousel_lg=&#8221;3&#8243; carousel_md=&#8221;2&#8243; carousel_sm=&#8221;1&#8243; thumb_size=&#8221;sixteen-nine&#8221; gutter_size=&#8221;3&#8243; post_items=&#8221;media|featured|onpost|original,date,title|-,text|excerpt|200,category|colorbg|relative|display-icon&#8221; carousel_height=&#8221;equal&#8221; carousel_interval=&#8221;3000&#8243; carousel_navspeed=&#8221;400&#8243; advanced_nav=&#8221;yes&#8221; el_id1=&#8221;index-974899&#8243; stage_padding=&#8221;0&#8243; single_back_color=&#8221;color-942029&#8243; single_overlay_opacity=&#8221;50&#8243; single_padding=&#8221;2&#8243; single_title_dimension=&#8221;h4&#8243; single_border=&#8221;yes&#8221; uncode_shortcode_id=&#8221;155558&#8243;][uncode_carousel_nav padding=&#8221;0&#8243; h_align=&#8221;center&#8221; hide_arrows=&#8221;yes&#8221; dots_style=&#8221;lines&#8221; hide_counter=&#8221;yes&#8221; uncode_shortcode_id=&#8221;207978&#8243; target=&#8221;index-974899&#8243; dot_single_width=&#8221;12&#8243; dot_single_active=&#8221;24&#8243; dot_single_height=&#8221;12&#8243; dot_single_radius=&#8221;999&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;0&#8243; back_color=&#8221;color-jevc&#8221; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; cvc_pattern_bottom_right=&#8221;pattern2&#8243; uncode_shortcode_id=&#8221;790913&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1770","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Okuvision: TES Therapy for retinitis pigmentosa (RP) \u2013 Evidence-Based<\/title>\n<meta name=\"description\" content=\"Official Okuvision Website: TES Therapy for retinitis pigmentosa, Studies, Real Experiences &amp; Care. Learn more now.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/okuvision.de\/en\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Okuvision Homepage\" \/>\n<meta property=\"og:description\" content=\"Official Okuvision Website: TES Therapy for retinitis pigmentosa, Studies, Real Experiences &amp; Care. Learn more now.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/okuvision.de\/en\/\" \/>\n<meta property=\"og:site_name\" content=\"Okuvision\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-03T12:33:15+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\",\"url\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\",\"name\":\"Okuvision: TES Therapy for retinitis pigmentosa (RP) \u2013 Evidence-Based\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#website\"},\"datePublished\":\"2025-07-24T15:10:16+00:00\",\"dateModified\":\"2026-05-03T12:33:15+00:00\",\"description\":\"Official Okuvision Website: TES Therapy for retinitis pigmentosa, Studies, Real Experiences & Care. Learn more now.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/okuvision.de\\\/en\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Okuvision Homepage\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\",\"name\":\"Okuvision\",\"description\":\"\u2013 Sehen erhalten\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/okuvision.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Okuvision: TES Therapy for retinitis pigmentosa (RP) \u2013 Evidence-Based","description":"Official Okuvision Website: TES Therapy for retinitis pigmentosa, Studies, Real Experiences & Care. Learn more now.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/okuvision.de\/en\/","og_locale":"en_US","og_type":"article","og_title":"Okuvision Homepage","og_description":"Official Okuvision Website: TES Therapy for retinitis pigmentosa, Studies, Real Experiences & Care. Learn more now.","og_url":"https:\/\/okuvision.de\/en\/","og_site_name":"Okuvision","article_modified_time":"2026-05-03T12:33:15+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/okuvision.de\/en\/","url":"https:\/\/okuvision.de\/en\/","name":"Okuvision: TES Therapy for retinitis pigmentosa (RP) \u2013 Evidence-Based","isPartOf":{"@id":"https:\/\/okuvision.de\/en\/#website"},"datePublished":"2025-07-24T15:10:16+00:00","dateModified":"2026-05-03T12:33:15+00:00","description":"Official Okuvision Website: TES Therapy for retinitis pigmentosa, Studies, Real Experiences & Care. Learn more now.","breadcrumb":{"@id":"https:\/\/okuvision.de\/en\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/okuvision.de\/en\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/okuvision.de\/en\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/okuvision.de\/en\/"},{"@type":"ListItem","position":2,"name":"Okuvision Homepage"}]},{"@type":"WebSite","@id":"https:\/\/okuvision.de\/en\/#website","url":"https:\/\/okuvision.de\/en\/","name":"Okuvision","description":"\u2013 Sehen erhalten","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/okuvision.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages\/1770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/comments?post=1770"}],"version-history":[{"count":85,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages\/1770\/revisions"}],"predecessor-version":[{"id":2540,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages\/1770\/revisions\/2540"}],"wp:attachment":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/media?parent=1770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}